SCHEMBL1796296

SCHEMBL1796296

COC(=O)NC(=O)c1ccc(C=NO)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
KMT2A Q03164 4/20 0.40
MAPT P10636 4/20 0.40
GFER P55789 2/20 0.40
KDM4E B2RXH2 4/20 0.39
MAPK1 P28482 1/20 0.39
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
POLB P06746 2/20 0.39
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
PAX8 Q06710 1/20 0.38
KLF5 Q13887 1/20 0.38
HIF1A Q16665 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1796295 1.00 LMNA (0.41) LMNAKMT2AMAPTGFERKDM4E
SCHEMBL1799259 0.84 ALDH1A1 (0.45) LMNAKMT2AMAPTKDM4ENPC1
SCHEMBL14963072 0.82 NPC1 (0.48) LMNAKMT2AMAPTGFERKDM4E
SCHEMBL3123464 0.82 NPC1 (0.48) LMNAKMT2AMAPTGFERKDM4E
SCHEMBL3123458 0.82 NPC1 (0.48) LMNAKMT2AMAPTGFERKDM4E
SCHEMBL30008909 0.82 NPC1 (0.48) LMNAKMT2AMAPTGFERKDM4E
SCHEMBL1796209 0.80 ALDH1A1 (0.38) LMNAKMT2AMAPTGFERKDM4E
SCHEMBL14963074 0.77 KMT2A (0.56) KMT2AMAPTGFERKDM4EMAPK1
SCHEMBL11055788 0.77 KMT2A (0.56) KMT2AMAPTGFERKDM4EMAPK1
SCHEMBL13822476 0.77 KMT2A (0.56) KMT2AMAPTGFERKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987464-B2 Isoxazoline-substituted benzamide compound and pesticide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-03-24 US disclosed
US-20140135496-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-05-15 US disclosed
US-8673951-B2 Isoxazoline-substituted benzamide compound and pesticide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-03-18 US disclosed
US-20110144334-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-06-16 US disclosed
US-7951828-B1 Isoxazoline-substituted benzamide compound and pesticide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-05-31 US disclosed
EP-1932836-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND HARMFUL ORGANISM-CONTROLLING AGENT Nissan Chemical Industries, Ltd. (JP) 2008-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144334-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE OR10J3, OR51E2, ORMDL3 LMNA 2151/4885KMT2A 2143/4885MAPT 4464/4885
US-20140135496-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE OR10J3, OR51E2, ODC1 LMNA 1930/4885KMT2A 1916/4885MAPT 3914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.